🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study for patients with head and neck cancer who will be receivin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00881114
This partially randomized phase I/II trial studies the side effects and bes...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2012-09-17
Trial ID
NCT01629498
This phase I trial studies the side effects and best dose of radiation ther...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2011-10
Trial ID
NCT01411098
This study will evaluate the safety of adding nivolumab to several chemothe...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2016-06
Trial ID
NCT02764593
"This phase I trial investigates the effect of radiation therapy on the imm...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-06-20
Trial ID
NCT05371132
Squamous cell carcinoma of unknown primary (SCCUP) site metastatic to cervi...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT02112344
Treatments Being Tested
Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced N...
Status
Unknown
Location
Xiaozhong Chen
Start Date
2017-01
Trial ID
NCT03058432
Treatments Being Tested
Single arm, phase Ib/2a dose escalation study with an expansion cohort to d...
Status
Completed
Location
UCLA Department of Radiation Oncology
Start Date
2017-04-01
Trial ID
NCT03349892
Treatments Being Tested
The goal of this clinical trial is to compare the survival and adverse reac...
Status
Recruiting
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Start Date
2024-03-25
Trial ID
NCT06533267
Treatments Being Tested
This phase 1b trial studies the side effects and best dose of TAS-102 when ...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2019-12-11
Trial ID
NCT04104139